New Therapeutic Options for Chemotherapy-Resistant Metastatic Breast Cancer: The Epothilones

ISSN： 0012-6667

Source： Drugs, Vol.68, Iss.2, 2008-01, pp. : 139-146

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic options for metastatic breast cancer

By Morris Patrick G McArthur Heather L Hudis Clifford A

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 6, 2009-04 ,pp. : 967-981

Informa Healthcare

Access to resources Recommend Favorite

Recurrent and/or metastatic thyroid cancer: therapeutic options

By Thalassinos Nicolaos Vlassopoulou Varvara Tzanela Marinela Karavitaki Niki Tzavara Ioanna

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 939-947

Informa Healthcare

Access to resources Recommend Favorite

Trastuzumab vs chemotherapy in metastatic breast cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 378, 2002-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Effectiveness and safety of eribulin mesylate: a new therapeutic option in the treatment of metastatic breast cancer

By O'Sullivan Coyne Geraldine Walsh Janice Kelly Catherine M

Expert Opinion on Drug Safety, Vol. 11, Iss. 4, 2012-07 ,pp. : 643-650

Informa Healthcare

Access to resources Recommend Favorite

New therapeutic options for advanced forms of thyroid cancer

By Bernet Victor Smallridge Robert

Expert Opinion on Emerging Drugs, Vol. 19, Iss. 2, 2014-06 ,pp. : 225-241

Informa Healthcare

Access to resources Recommend Favorite